ISPOR MEMBERS ONLY Educational Webinar: Prove it with PROs?

January 24, 2019
11:00 AM EDT - 1 hour in duration
Click here for time zone conversion

Speakers: Anke van Engen, Yvonne-Beatrice Boehler, Stefan Holmstrom, Finn Boerlum Kristensen

Health Technology Assessment (HTA) bodies worldwide recognize the importance of demonstrating the impact of new drugs on patient-relevant outcomes (PRO). However, to date PRO data has had a limited impact on HTA decision-making. The webinar will discuss the path forward to increase the value of PRO data to inform HTA decision-making. PRO data is increasingly included in HTA submissions, but is rarely a decision driver. The extent to which PROs are being assessed, and the influence the data has on HTA recommendations, varies between HTA bodies as their data requirements and assessment methods differ.

This webinar will feature four expert panelists, who will lead you through essential aspects of “proving it with PROs”.

What You Will Learn:

  • Anke van Engen, MSc, IQVIA, Amsterdam, The Netherlands, will first describe the impact of PRO data in HTAs in different therapeutic areas and different countries. IQWiG has clear guidelines on the assessment of PRO data and Germany is one the exceptions where the impact of PRO data on HTA decision-making is more transparent.
  • Yvonne-Beatrice Boehler, MD, MBA, TH Koeln, University of Applied Sciences, Leverkusen Germany, will present IQWiG’s methodology for assessing symptoms and functional scales; highlight common issues seen with the submitted PRO data and set out what manufacturers need to do in order to be successful.
  • Stefan Holmstrom, Astellas, Leiden, The Netherlands, will offer the industry perspective, discussing an example highlighting some of the key challenges in convincing HTA bodies of patient-relevant improvements and illustrating that better guidance from HTA bodies is required. The industry also must present evidence in a more user-friendly format.
  • Finn Boerlum Kristensen, MD, PhD, University of Southern Denmark, Odense, Denmark, will present the value assessment of the patient and social aspects in the Core Model developed by EUnetHTA and argue that there can be more consensus and emphasis on PROs by including them more prominently in the HTA Core Model.

The audience will be invited to share their thoughts on how to increase the impact of PROs on HTA decisions and share best practices in collecting and assessing PRO data.

This is a Members ONLY webinar.

Members will receive an official member invitation via Email.

Not a member?

Join ISPOR Here


Anke van Engen, MSc
Senior Principal, Consulting Services
The Netherlands

Yvonne-Beatrice Boehler, MD, MBA
Vice Dean and Professor for Science and Knowledge Transfer Specialty
TH Koeln
University of Applied Sciences

Stefan Holmstrom, BSc, MSc
HTA Strategy and PRO excellence, Head
Leiden, The Netherlands

Finn Boerlum Kristensen, MD, PhD
Professor in Health Services Research and HTA
Health Sciences Dept.
University of Southern Denmark
Odense, Denmark

Please note: On the day of the scheduled webinar, the first 500 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 weeks after the scheduled Webinar.

Reservations are on a first-come, first-served basis for all ISPOR members.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now